DARMSTADT, Germany, and WASHINGTON, April 14, 2016
DARMSTADT, Germany, and WASHINGTON, April 14, 2016 /PRNewswire/ -- Merck KGaA, Darmstadt, Germany, a leading science and technology company which operates as EMD Serono, MilliporeSigma and EMD Performance Materials in the United States and Canada today announced that it is participating in the 4th USA Science & Engineering Festival (USASEF), April 16-17, 2016 in Washington D.C. The festival is the largest Science, Technology, Engineering and Mathematic (STEM) gathering in the United States, bringing together more than 350,000 K-12 students and parents, as well as more than 5,000 teachers and 3,000 professionals.
"The USA Science & Engineering Festival aligns with our company's commitment to furthering STEM education and igniting a passion for science in the next generation of innovators," said Gary Zieziula, President and Managing Director of EMD Serono, which is Merck KGaA, Darmstadt, Germany'sNorth America biopharma business. "Our participation in the festival is just one example of how we are providing hands-on learning to students of all ages to spur curiosity and innovation."
Researchers representing the company's three businesses sectors - Healthcare, Life Science, and Performance Materials - will guide festival participants through experiments that are at the heart of their work in the laboratory and illustrate important societal challenges:
The company has a long tradition of supporting cultural and educational programs around the world and fostering an interest in science. It's Smarter Together in the Classroom program provides public schools in Massachusetts as well as St. Louis, Missouri, with critical funding for projects that explore pressing scientific questions. In addition, MilliporeSigma's SPARK global skills-based volunteer program provides volunteer opportunities for its network of employees, with a focus on science education.
For a hands-on look at experiments used in real-world applications and to learn more about Merck KGaA, Darmstadt, Germany, please visit Booth 715 in Exhibit Hall A.
About Merck KGaA, Darmstadt, Germany
All Merck KGaA, Darmstadt, Germany, press releases are distributed by e-mail at the same time they become available on the EMD Group Website. In case you are a resident of the USA or Canada please go to www.emdgroup.com/subscribe to register again for your online subscription of this service as our newly introduced geo-targeting requires new links in the email. You may later change your selection or discontinue this service.
Merck KGaA, Darmstadt, Germany, is a leading science and technology company in healthcare, life science and performance materials. Around 50,000 employees work to further develop technologies that improve and enhance life – from biopharmaceutical therapies to treat cancer or multiple sclerosis, cutting-edge systems for scientific research and production, to liquid crystals for smartphones and LCD televisions. In 2015, Merck KGaA, Darmstadt, Germany, generated sales of € 12.85 billion in 66 countries.
Founded in 1668, Merck KGaA, Darmstadt, Germany, is the world's oldest pharmaceutical and chemical company. The founding family remains the majority owner of the publicly listed corporate group. Merck KGaA, Darmstadt, Germany operates as EMD Serono, MilliporeSigma and EMD Performance Materials in the United States and Canada.
Melissa Manganello +1-781-681-2393
Head Media Relations -62445
Spokesperson: -9591 / -7144 / -6328
Fax +49 6151 72 3138
To view the original version on PR Newswire, visit:http://www.prnewswire.com/news-releases/merck-kgaa-darmstadt-germany-supports-next-generation-of-scientists-at-usa-science--engineering-festival-300251811.html
SOURCE Merck KGaA, Darmstadt, GermanyPR Newswire
Last updated on: 14/04/2016
PharmiWeb.com is Europe's leading industry-sponsored portal for the Pharmaceutical sector, providing the latest jobs, news, features and events listings.
The information provided on PharmiWeb.com is designed to support, not replace, the relationship that exists between a patient/site visitor and his/her physician.